Help Get Prepared For Peak Respiratory Illness Season

During fall and winter, it's especially important to include the respiratory vaccines that are right for you as part of your preventative health routine. Ask your doctor or pharmacist which respiratory vaccines you need or check eligibility and book in minutes at VaxAssist.com.

You've Still Got It: Aging with Agency to Stay on Top of Your Health Year-Round

Embrace Aging with Agency by taking control of your health through preventive care, regular checkups, and vaccinations to stay strong, confident, and healthy all year long.

Health Answers by Pfizer

Health Answers by Pfizer is a consumer digital experience powered by generative artificial intelligence that allows you to ask your biggest and smallest health and wellness questions - anytime, anywhere - and receive real-time, relevant responses and next steps.

Developing a Path Forward in Cancer Cachexia

Driven by his personal experience, Matthew brings deep purpose to his work each day - advancing science with the hope of delivering a treatment for cancer cachexia, a metabolic condition resulting in severe weight loss and muscle wasting.

Accord for a Healthier World: Introducing the Africa Health Experts Network

Driven by the vision that where you live should not impact the quality of your care, Pfizer's Accord for a Healthier World is collaborating with governments and experts across Africa to help address national healthcare systemic challenges.

A Cancer Breakthrough You Should Know About: Antibody-Drug Conjugates

A type of medicine called an "antibody-drug conjugate" is changing the landscape of cancer treatments. Find out how they work and how Pfizer has been leading the way in development.

Items of Interest

Have a Question About Your Benefits?

Visit the Pfizer Benefits Center for answers!

Visit the
Community Corner

Connect with former colleagues, view recent retirements and more!

Connected. Active. Involved.

Welcome to the official website for retirees of Pfizer and its legacy organizations.


Pfizer News

Pfizer Completes Acquisition of Metsera
November 13, 2025
Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference
November 12, 2025
Pfizer Responds to Delaware Chancery Court Ruling
November 05, 2025
Pfizer Files Lawsuit Against Metsera and its Directors and Novo Nordisk for Breach of Merger Agreement
October 31, 2025
Pfizer Receives Early Clearance from U.S. Federal Trade Commission for Metsera Acquisition
October 31, 2025
Pfizer Addresses Proposal for Metsera
October 30, 2025
XTANDI® Plus Leuprolide Reduced Risk of Death by 40% vs Leuprolide Alone in Men with a Type of Advanced Prostate Cancer
October 19, 2025
Pfizer's BRAFTOVI® + MEKTOVI® Shows Sustained Long-Term Survival in Patients with Advanced Lung Cancer
October 19, 2025
PADCEVTM Plus KEYTRUDATM, Given Before and After Surgery, Cuts the Risk of Recurrence, Progression or Death by 60% and the Risk of Death by 50% for Certain Patients with Bladder Cancer
October 18, 2025
TUKYSA Combination Significantly Improves Progression-Free Survival as First-Line Maintenance in HER2+ Metastatic Breast Cancer in HER2CLIMB-05 Trial
October 14, 2025
Pfizer to Highlight Advancements in Respiratory Health and Infectious Disease Research at IDWeek 2025
October 13, 2025
Pfizer Declares Fourth-Quarter 2025 Dividend
October 09, 2025
Pfizer Reaches Landmark Agreement with U.S. Government to Lower Drug Costs for American Patients
September 30, 2025
Pfizer Highlights Momentum in Redefining Standards of Care in Cancer at ESMO 2025
September 25, 2025
Pfizer Invites Public to View and Listen to Webcast of November 4 Conference Call with Analysts
September 23, 2025
Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio
September 22, 2025
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
September 08, 2025
Pfizer and BioNTech's COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 27, 2025
PADCEVTM Plus KEYTRUDATM Significantly Improves Survival for Certain Patients with Bladder Cancer When Given Before and After Surgery
August 12, 2025
Pfizer Reports Strong Second-Quarter 2025 Results And Raises 2025 EPS Guidance
August 05, 2025
Pfizer and BioNTech Receive Positive CHMP Opinion for LP.8.1-adapted COVID-19 Vaccine in the European Union
July 25, 2025
Pfizer Completes Licensing Agreement with 3SBio
July 24, 2025
XTANDI® Plus Leuprolide Significantly Improves Survival Outcomes in Men with Non-Metastatic Hormone-Sensitive Prostate Cancer with High-Risk Biochemical Recurrence
July 10, 2025

Click here to view all Pfizer News stories.

Join the Pfizer Plus Community Corner

When you join the PfizerPlus.com community, you can get access to our special “member’s only” features including:

  • Member Only Content
  • Email Updates
  • PfizerPlus.com Community